Advertisement
Commentaries| Volume 60, ISSUE 3, P215-216, March 2007

Cost-effectiveness of different study designs: an overlooked parameter in clinical research

      Certain research questions can be answered only by a particular study design, whereas others may be examined by more than one study designs [
      • MacMahon S.
      • Collins R.
      Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies.
      ,
      • Sackett D.L.
      • Wennberg J.E.
      Choosing the best research design for each question.
      ]. Thus, researchers are frequently puzzled to decide what is the appropriate study design to answer a specific research hypothesis. There have been several published analyses that have compared the results of studies examining the same research hypothesis using different methodologies [
      • Deeks J.J.
      • Dinnes J.
      • D'Amico R.
      • Sowden A.J.
      • Sakarovitch C.
      • Song F.
      • et al.
      Evaluating non-randomised intervention studies.
      ]. The results of most of these analyses showed that the findings of well-designed cohort studies are similar to those of randomized controlled trials (RCTs) [
      • Deeks J.J.
      • Dinnes J.
      • D'Amico R.
      • Sowden A.J.
      • Sakarovitch C.
      • Song F.
      • et al.
      Evaluating non-randomised intervention studies.
      ,
      • Concato J.
      • Shah N.
      • Horwitz R.I.
      Randomized, controlled trials, observational studies, and the hierarchy of research designs.
      ]. However, these systematic analyses did not compare the cost of each study design, an issue commonly overlooked when evaluating the appropriateness of a research methodology for a given research hypothesis. Unfortunately, there are very few published data regarding the actual cost or the cost effectiveness of published studies [
      • Bennett C.L.
      • Adams J.R.
      • Knox K.S.
      • Kelahan A.M.
      • Silver S.M.
      • Bailes J.S.
      • et al.
      Clinical trials: are they a good buy?.
      ,
      • Detsky A.S.
      Are clinical trials a cost-effective investment?.
      ]; we managed to identify only one study that focused on the comparison of the cost effectiveness between different study designs examining the same research hypothesis [
      • Hak E.
      • Wei F.
      • Grobbee D.E.
      • Nichol K.L.
      A nested case-control study of influenza vaccination was a cost-effective alternative to a full cohort analysis.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Clinical Epidemiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • MacMahon S.
        • Collins R.
        Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies.
        Lancet. 2001; 357: 455-462
        • Sackett D.L.
        • Wennberg J.E.
        Choosing the best research design for each question.
        BMJ. 1997; 315: 1636
        • Deeks J.J.
        • Dinnes J.
        • D'Amico R.
        • Sowden A.J.
        • Sakarovitch C.
        • Song F.
        • et al.
        Evaluating non-randomised intervention studies.
        Health Technol Assess. 2003; 7: 1-173
        • Concato J.
        • Shah N.
        • Horwitz R.I.
        Randomized, controlled trials, observational studies, and the hierarchy of research designs.
        N Engl J Med. 2000; 342: 1887-1892
        • Bennett C.L.
        • Adams J.R.
        • Knox K.S.
        • Kelahan A.M.
        • Silver S.M.
        • Bailes J.S.
        • et al.
        Clinical trials: are they a good buy?.
        J Clin Oncol. 2001; 19: 4330-4339
        • Detsky A.S.
        Are clinical trials a cost-effective investment?.
        JAMA. 1989; 262: 1795-1800
        • Hak E.
        • Wei F.
        • Grobbee D.E.
        • Nichol K.L.
        A nested case-control study of influenza vaccination was a cost-effective alternative to a full cohort analysis.
        J Clin Epidemiol. 2004; 57: 875-880
        • Moussa M.A.
        Planning a clinical trial with allowance for cost and patient recruitment rate.
        Comput Programs Biomed. 1984; 18: 173-179
        • Wilson S.
        • Delaney B.
        • Roalfe A.
        • Hobbs R.
        Clinical trials in primary care. Costs of research should not be borne by service practitioners.
        BMJ. 1999; 318: 1484
        • Moons C.K.
        • van Es G.A.
        • Stijnen T.
        • Bak A.A.
        • Hofman A.
        • Jonker J.J.
        • et al.
        Efficiency optimization of the selection period in therapeutic trials.
        J Clin Epidemiol. 1997; 50: 793-800
        • Kennedy B.J.
        Excessive test costs in clinical research protocols.
        J Cancer Educ. 1991; 6: 93-97
        • Thach C.T.
        • Fisher L.D.
        Self-designing two-stage trials to minimize expected costs.
        Biometrics. 2002; 58: 432-438
        • Ware J.H.
        • Muller J.E.
        • Braunwald E.
        The futility index. An approach to the cost-effective termination of randomized clinical trials.
        Am J Med. 1985; 78: 635-643
        • Andrieu N.
        • Goldstein A.M.
        The case-combined-control design was efficient in detecting gene-environment interactions.
        J Clin Epidemiol. 2004; 57: 662-671
        • Hudson J.I.
        • Pope Jr., H.G.
        • Glynn R.J.
        The cross-sectional cohort study: an underutilized design.
        Epidemiology. 2005; 16: 355-359
        • Etminan M.
        Pharmacoepidemiology II: the nested case-control study—a novel approach in pharmacoepidemiologic research.
        Pharmacotherapy. 2004; 24: 1105-1109